NCT04943419View on ClinicalTrials.gov

Myeloid-derived Suppressor Cells in Colorectal Cancer

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

April 1, 2016

Primary Completion Date

February 27, 2021

Study Completion Date

June 21, 2021

Conditions
Colorectal CancerSuppressionComplication,PostoperativeRadiotherapy
Interventions
DIAGNOSTIC_TEST

Level of Myeloid-Derived Suppressor Cells

Establishing of levels of all MDSC, PMNMDSC, MMDSC, EMDSC, M/PMN MDSC ratio on the day before operation.

Trial Locations (1)

31-501

1st Department of General Surgery, Krakow

All Listed Sponsors
lead

Jagiellonian University

OTHER

NCT04943419 - Myeloid-derived Suppressor Cells in Colorectal Cancer | Biotech Hunter | Biotech Hunter